Name
Mymed Perearstid OÜ
Registry code
14158450
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
25.11.2016 (7)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment 68201 - Rental and operating of own or leased real estate
494 813 €
67 268 €
14%
2 639 €
(estimate is approximate)
207 756 €
5
Submitted
No tax arrears
32%
26%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Karin Pärnpuu 11.05.1973 (51) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| Epp Alas Saarts 10.10.1991 (32) | - | - | - | Founder |
| 2019 15.07.2020 | 2020 21.07.2021 | 2021 16.03.2022 | 2022 03.12.2023 | 2023 11.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 135 486 € | 382 938 € | 496 345 € | 619 669 € | 494 813 € |
| Net profit (loss) for the period | 5 962 € | 8 822 € | 80 333 € | 124 288 € | 67 268 € |
| Profit Margin | 4% | 2% | 16% | 20% | 14% |
| Current Assets | 27 507 € | 71 039 € | 136 632 € | 186 662 € | 143 252 € |
| Fixed Assets | 5 806 € | 34 393 € | 31 011 € | 15 989 € | 112 400 € |
| Total Assets | 33 313 € | 105 432 € | 167 643 € | 202 651 € | 255 652 € |
| Current Liabilities | 25 282 € | 48 862 € | 53 828 € | 51 410 € | 47 896 € |
| Non Current Liabilities | - | 39 717 € | 26 629 € | 0 € | 0 € |
| Total Liabilities | - | 88 579 € | 80 457 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 8 031 € | 16 853 € | 87 186 € | 151 241 € | 207 756 € |
| Employees | 3 | 5 | 6 | 7 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 33 725.86 € | 29 497.05 € | 12 |
| 2023 Q4 | - | 23 985.82 € | 25 770.92 € | 10 |
| 2023 Q3 | - | 18 193.19 € | 19 588.66 € | 9 |
| 2023 Q2 | - | 16 619.29 € | 15 960.33 € | 9 |
| 2023 Q1 | - | 24 608.94 € | 26 513.47 € | 9 |
| 2022 Q4 | - | 23 617.54 € | 25 426.59 € | 11 |
| 2022 Q3 | - | 23 713.33 € | 25 533.95 € | 13 |
| 2022 Q2 | - | 21 592.79 € | 23 230.6 € | 12 |
| 2022 Q1 | - | 40 751.34 € | 28 031.42 € | 12 |
| 2021 Q4 | - | 18 683.78 € | 20 157.56 € | 11 |
| 2021 Q3 | - | 21 251.88 € | 23 003.29 € | 12 |
| 2021 Q2 | - | 21 928.58 € | 23 782.14 € | 11 |
| 2021 Q1 | - | 18 150.03 € | 16 987.4 € | 9 |
| 2020 Q4 | - | 13 062.46 € | 14 161.85 € | 9 |
| 2020 Q3 | - | 14 284.32 € | 15 484.75 € | 8 |
| 2020 Q2 | - | 10 677.32 € | 11 575.45 € | 8 |
| 2020 Q1 | - | 10 491.81 € | 11 374.83 € | 4 |
